Rapid Molecular Diagnostics in Vulvovaginal Candidosis
Diagnostics · 17.10.2024 · 14 (20) · 2313
DOI: 10.3390/diagnostics14202313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 17.10.2024. Verfasst von Karolina Akinosoglou und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Patras, 26504 Rio, Greece. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Vulvovaginal candidosis (VVC) is a common condition among women, with current diagnostic methods relying on clinical evaluation and laboratory testing. These traditional methods are often limited by the need for specialized training, variable performance, and lengthy diagnostic processes, leading to delayed treatment and inappropriate antifungal use. This review evaluates the efficacy of molecular diagnostic tools for VVC and provides guidance on their application in clinical practice.
Methods
A literature search was conducted using PubMed to identify studies evaluating rapid diagnostic tests specifically for vulvovaginal Candida isolates. Inclusion criteria focused on studies utilizing molecular diagnostics for the detection of Candida species in VVC. Articles discussing non-vaginal Candida infections, non-English studies, and animal or in vitro research were excluded.
Results
Twenty-three studies met the inclusion criteria, predominantly evaluating nucleid acid amplification tests/polymerase chain reaction (NAAT/PCR) assays and DNA probes. PCR/NAAT assays demonstrated high sensitivity and specificity (>86%) for VVC diagnosis, outperforming conventional diagnostic methods. Comparatively, DNA probes, while simpler, exhibited lower sensitivity. The included studies were mostly observational, with only one randomized controlled trial. Emerging diagnostic technologies, including artificial intelligence and integrated testing models, show promise for improving diagnostic precision and clinical outcomes.
Conclusions
Molecular diagnostics offer a significant improvement in VVC management, though traditional methods remain valuable in resource-limited settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Patras, 26504 Rio, Greece.
- Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Rio, Greece.
- Femicare, Clinical Research for Women, 3300 Tienen, Belgium.
- Regional Hospital Heilig Hart, 3300 Tienen, Belgium.
- Department of Obstetrics and Gynecology, University Hospital Antwerpen, 2650 Antwerp, Belgium.
ORCID-Profile: Karolina Akinosoglou, Georgios Schinas, Sabriye Ozcelik, Francesca Donders, Gilbert Donders
Zitieren
APA
Akinosoglou, K., Schinas, G., Papageorgiou, D., Polyzou, E., Massie, Z., Ozcelik, S., Donders, F., & Donders, G. (2024). Rapid Molecular Diagnostics in Vulvovaginal Candidosis. Diagnostics, 14(20), 2313. https://doi.org/10.3390/diagnostics14202313
Vancouver
Akinosoglou K, Schinas G, Papageorgiou D, Polyzou E, Massie Z, Ozcelik S, et al. Rapid Molecular Diagnostics in Vulvovaginal Candidosis. Diagnostics. 2024;14(20):2313. doi:10.3390/diagnostics14202313
BibTeX
@article{Akinosoglou2024,
author = {Akinosoglou, Karolina and Schinas, Georgios and Papageorgiou, Despoina and Polyzou, Eleni and Massie, Zoe and Ozcelik, Sabriye and Donders, Francesca and Donders, Gilbert},
title = {Rapid Molecular Diagnostics in Vulvovaginal Candidosis},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {20},
pages = {2313},
doi = {10.3390/diagnostics14202313}
}
EUVIMED